What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?
Holzbeierlein
Jeffrey M
JM
Department of Urology, University of Kansas Hospital, Kansas City, KS 66160, USA. jholzbeierlein@kumc.edu
D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced / Q000209:etiology*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
D000726:Androgen Antagonists